Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- NARA ID
- findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Investigation
- Released
- 2023-01-25
- Slug
- doj-oig-findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Indexed
- 2026-04-27 05:02:03
More from DOJ OIG — Drug Enforcement Administration
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration (DEA) Executive Assistant for Misuse of Position, Prohibited Association with a Former DEA Confidential Source, and Soliciting and Accepting Gifts from the Former DEA Confidential Source
- Audit of the Drug Enforcement Administration's Regional Linguist Services Contract Awarded to Conduit Language Specialists, Inc.
- Audit of the Drug Enforcement Administration’s El Paso Intelligence Center Seizure System Pursuant to the Federal Information Security Modernization Act of 2014, Fiscal Year 2024
- Audit of the Drug Enforcement Administration’s Mobile Enforcement Team Program
- Review of the Drug Enforcement Administration’s Accounting of Drug Control Funding Fiscal Year 2025
- Investigative Summary: Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.